FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103295541> ?p ?o ?g. }

• W2103295541 endingPage "1042" @default.
• W2103295541 startingPage "1042" @default.
• W2103295541 abstract "<h3>Importance</h3> Pay for performance is intended to align incentives to promote high-quality care, but results have been contradictory. <h3>Objective</h3> To test the effect of explicit financial incentives to reward guideline-recommended hypertension care. <h3>Design, Setting, and Participants</h3> Cluster randomized trial of 12 Veterans Affairs outpatient clinics with 5 performance periods and a 12-month washout that enrolled 83 primary care physicians and 42 nonphysician personnel (eg, nurses, pharmacists). <h3>Interventions</h3> Physician-level (individual) incentives, practice-level incentives, both, or none. Intervention participants received up to 5 payments every 4 months; all participants could access feedback reports. <h3>Main Outcomes and Measures</h3> Among a random sample, number of patients achieving guideline-recommended blood pressure thresholds or receiving an appropriate response to uncontrolled blood pressure, number of patients prescribed guideline-recommended medications, and number who developed hypotension. <h3>Results</h3> Mean (SD) total payments over the study were $4270 ($459), $2672 ($153), and $1648 ($248) for the combined, individual, and practice-level interventions, respectively. The unadjusted baseline and final percentages and the adjusted absolute change over the study in patients meeting the combined blood pressure/appropriate response measure were 75% to 84% and 8.84% (95% CI, 4.20% to 11.80%) for the individual group, 80% to 85% and 3.70% (95% CI, 0.24% to 7.68%) for the practice-level group, 79% to 88% and 5.54% (95% CI, 1.92% to 9.52%) for the combined group, and 86% to 86% and 0.47% (95% CI, −3.12% to 4.04%) for the control group. The adjusted absolute estimated difference in the change between the proportion of patients with blood pressure control/appropriate response for individual incentive and control groups was 8.36% (95% CI, 2.40% to 13.00%; P=.005). The other incentive groups did not show a significant change compared with controls for this outcome. For medications, the unadjusted baseline and final percentages and the adjusted absolute change were 61% to 73% and 9.07% (95% CI, 4.52% to 13.44%), 56% to 65% and 4.98% (95% CI, 0.64% to 10.08%), 65% to 80% and 7.26% (95% CI, 2.92% to 12.48%), and 63% to 72% and 4.35% (95% CI, −0.28% to 9.28%), respectively. These changes in the use of guideline-recommended medications were not significant in any of the incentive groups compared with controls, nor was the incidence of hypotension. The effect of the incentive was not sustained after a washout. <h3>Conclusions and Relevance</h3> Individual financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure; none of the incentives resulted in greater use of guideline-recommended medications or increased incidence of hypotension compared with controls. Further research is needed on the factors that contributed to these findings. <h3>Trial Registration</h3> clinicaltrials.gov Identifier:NCT00302718" @default.
• W2103295541 created "2016-06-24" @default.
• W2103295541 creator A5004052093 @default.
• W2103295541 creator A5029334068 @default.
• W2103295541 creator A5030245140 @default.
• W2103295541 creator A5052786052 @default.
• W2103295541 creator A5057148501 @default.
• W2103295541 creator A5059250797 @default.
• W2103295541 creator A5068535612 @default.
• W2103295541 creator A5088259680 @default.
• W2103295541 creator A5091106247 @default.
• W2103295541 date "2013-09-11" @default.
• W2103295541 modified "2023-09-29" @default.
• W2103295541 title "Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care" @default.
• W2103295541 cites W1562208008 @default.
• W2103295541 cites W1587990062 @default.
• W2103295541 cites W1596515083 @default.
• W2103295541 cites W1680974218 @default.
• W2103295541 cites W1966640106 @default.
• W2103295541 cites W1970518419 @default.
• W2103295541 cites W1978403711 @default.
• W2103295541 cites W1980911127 @default.
• W2103295541 cites W1983736621 @default.
• W2103295541 cites W1986900160 @default.
• W2103295541 cites W1989649405 @default.
• W2103295541 cites W1995416328 @default.
• W2103295541 cites W1997182468 @default.
• W2103295541 cites W2034065282 @default.
• W2103295541 cites W2042630906 @default.
• W2103295541 cites W2050387573 @default.
• W2103295541 cites W2091539754 @default.
• W2103295541 cites W2105933035 @default.
• W2103295541 cites W2111086404 @default.
• W2103295541 cites W2111098388 @default.
• W2103295541 cites W2112238954 @default.
• W2103295541 cites W2126031808 @default.
• W2103295541 cites W2147558664 @default.
• W2103295541 cites W2156121263 @default.
• W2103295541 cites W2164870148 @default.
• W2103295541 cites W2169408555 @default.
• W2103295541 cites W2295088249 @default.
• W2103295541 cites W2316183586 @default.
• W2103295541 cites W2484403390 @default.
• W2103295541 cites W2562329777 @default.
• W2103295541 cites W2621832667 @default.
• W2103295541 cites W2885002515 @default.
• W2103295541 doi "https://doi.org/10.1001/jama.2013.276303" @default.
• W2103295541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4165573" @default.
• W2103295541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24026599" @default.
• W2103295541 hasPublicationYear "2013" @default.
• W2103295541 type Work @default.
• W2103295541 sameAs 2103295541 @default.
• W2103295541 citedByCount "101" @default.
• W2103295541 countsByYear W21032955412013 @default.
• W2103295541 countsByYear W21032955412014 @default.
• W2103295541 countsByYear W21032955412015 @default.
• W2103295541 countsByYear W21032955412016 @default.
• W2103295541 countsByYear W21032955412017 @default.
• W2103295541 countsByYear W21032955412018 @default.
• W2103295541 countsByYear W21032955412019 @default.
• W2103295541 countsByYear W21032955412020 @default.
• W2103295541 countsByYear W21032955412021 @default.
• W2103295541 countsByYear W21032955412022 @default.
• W2103295541 countsByYear W21032955412023 @default.
• W2103295541 crossrefType "journal-article" @default.
• W2103295541 hasAuthorship W2103295541A5004052093 @default.
• W2103295541 hasAuthorship W2103295541A5029334068 @default.
• W2103295541 hasAuthorship W2103295541A5030245140 @default.
• W2103295541 hasAuthorship W2103295541A5052786052 @default.
• W2103295541 hasAuthorship W2103295541A5057148501 @default.
• W2103295541 hasAuthorship W2103295541A5059250797 @default.
• W2103295541 hasAuthorship W2103295541A5068535612 @default.
• W2103295541 hasAuthorship W2103295541A5088259680 @default.
• W2103295541 hasAuthorship W2103295541A5091106247 @default.
• W2103295541 hasBestOaLocation W21032955411 @default.
• W2103295541 hasConcept C126322002 @default.
• W2103295541 hasConcept C142724271 @default.
• W2103295541 hasConcept C159110408 @default.
• W2103295541 hasConcept C162324750 @default.
• W2103295541 hasConcept C168563851 @default.
• W2103295541 hasConcept C175444787 @default.
• W2103295541 hasConcept C1862650 @default.
• W2103295541 hasConcept C194828623 @default.
• W2103295541 hasConcept C27415008 @default.
• W2103295541 hasConcept C2775969662 @default.
• W2103295541 hasConcept C2776204158 @default.
• W2103295541 hasConcept C2780182762 @default.
• W2103295541 hasConcept C29122968 @default.
• W2103295541 hasConcept C512399662 @default.
• W2103295541 hasConcept C71924100 @default.
• W2103295541 hasConcept C84393581 @default.
• W2103295541 hasConceptScore W2103295541C126322002 @default.
• W2103295541 hasConceptScore W2103295541C142724271 @default.
• W2103295541 hasConceptScore W2103295541C159110408 @default.
• W2103295541 hasConceptScore W2103295541C162324750 @default.
• W2103295541 hasConceptScore W2103295541C168563851 @default.
• W2103295541 hasConceptScore W2103295541C175444787 @default.
• W2103295541 hasConceptScore W2103295541C1862650 @default.

• next